^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

GLPG5201

i
Other names: GLPG5201, 5201, BCN-CP01, BCNCP01, BCN CP01, GLPG-5201, GLPG 5201, '5201
Associations
Trials
Company:
Galapagos
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials